Abstract
Within the group of vascular malformations, the capillary malformations (CM), more commonly known as port wine stains, are the most frequently occurring and have the highest epidemiological profile. They are characterised by the presence of capillary anomalies at the level of the papillary and reticular regions of the dermis: the vessels are permanently dilated, giving rise to the typical skin colouration that can vary from pale red to deep purple. They are present at birth in 0.3% of newborns with an equal distribution between the two sexes. The extent of the CM can vary from a few millimetres to over 50% of the body surface, affecting almost any somatic region, although port wine stains occur most frequently on the head and neck. When they occur on the face, over 50% of the CMs affect only one of the three cutaneous areas corresponding to the sensory branches of the trigeminal nerve. Clinical diagnosis is normally straightforward with a skin biopsy only rarely necessary for confirmation. CMs do not regress but grow according to the somatic development of the individual, and over the years, the surface becomes darker and subject to such phenomena as thickening and nodular hypertrophy (cobbling). In adulthood, these phenomena may cause significant clinical conditions, with the increased disfigurement leading to psychological damage and sometimes very marked functional disorder. Even less clinically significant cases are capable, from early infancy, of producing negative effects on a child’s cognitive, social and psychological development with inevitable repercussions in adult life. To this can be added the anxiety and sense of guilt that normally afflict the parents, emotional factors that can complicate problems of family equilibrium to the extent that this pathology can be considered a condition that is not limited to a merely aesthetic issue. For these reasons, requests for treatment are becoming ever more numerous, particularly now that the proliferation of new communications media makes it easier to access detailed information about the technological solutions available and the clinical issues that accompany them. It is known that this condition is associated with some syndromes, the most well known and frequently occurring is Sturge-Weber syndrome, which can be observed in particular in patients with a port wine stain affecting the part of the skin corresponding to the first branch (V1) of the trigeminal nerve.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Nguyen V, Hochman M, Mihm MC Jr, Nelson JS, Tan W. The pathogenesis of port wine stain and sturge weber syndrome: complex interactions between genetic alterations and aberrant MAPK and PI3K activation. Int J Mol Sci. 2019;20(9):2243. https://doi.org/10.3390/ijms20092243.
Achauer BM, Chang CJ, Vander Kam VM. Management of hemangioma of infancy: review of 245 patients. Plast Reconstr Surg. 1997;99:1301–8.
Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524–7.
Braur JA, Geronemus RG. Laser treatment in the management of infantile hemangiomas and capillary vascular malformations. Tech Vasc Interv Radiol. 2013;16:51–4.
Brightman LA, Brauer JA, Terushkin V, et al. Ablative fractional resurfacing for involuted hemangioma residuum. Arch Dermatol. 2012;148:1294–8.
Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol. 2012;29:28–31.
Chen JK, Ghasri P, Aguilar G, van Drooge AM, Wolkerstorfer A, Kelly KM, et al. An overview of clinical and experimental treatment modalities for port-wine stains. J Am Acad Dermatol. 2012;67(2):289–304.
Craiglow BG, Antaya RJ. Management of infantile hemangiomas: current potential pharmacotherapeutic approaches. Pediatr Drugs. 2013;15:133–8.
Greenberger S, Bischoff J. Pathogenesis of infantile hemangioma. Br J Dermatol. 2013;169:12–9.
Greenwald J, Rosen S, Anderson RR, Harrist T, MacFarland F, Noe J, et al. Comparative histological studies of the tunable dye laser and argon laser: the specific vascular effects of the dye laser. J Invest Dermatol. 1981;77:305–10.
Huikeshoven M, Koster PH, de Borgie CA, et al. Redarkening of port-wine stains 10 years after pulsed-dye-laser treatment. N Engl J Med. 2007;356(12):1235–40.
Hzura GJ, Geronemus RG, Dover JS, Arndt KA. Lasers in dermatology-1993. Arch Dermatol. 1993;129:1026–35.
Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr. 2010;157:795–801.
Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976;58(2):218–22.
Jasim ZF, Handley JM. Treatment of pulsed dye laser-resistant port wine stain birthmarks. J Am Acad Dermatol. 2007;57(4):677–82.
Kwon EK, Seefeldt M, Drolet BA. Infantile hemangiomas: an update. Am J Clin Dermatol. 2013;14:111–23.
Landthaler M, Hohenleutner U. Laser therapy of vascular lesions. Photodermatol Photoimmunol Photomed. 2006;22:324–32.
Leaute-Labreze C, de la Dumas RE, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–51.
Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011;25(11):1245–53.
Maguiness SM, Frieden IJ. Management of difficult infantile hemangiomas. Arch Dis Child. 2012;97:266–71.
Marqueling AL, Oza V, Frieden IJ, et al. Propranolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013;30:182–91.
McCuaig CC, Dubois J, Powell J, et al. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol. 2009;26:203–12.
Metry D, Frieden IJ, Hess C, et al. Propranolol use in PHACE syndrome with cervical intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol. 2013;30:71–89.
Naran S, Gilmore J, Deleyiannis FW. The assessment of port-wine stains in children following multiple pulsed-dye laser treatments. Ann Plast Surg. 2008;60(4):426–30.
Ni N, Guo S, Langer P. Current concepts in the management of periocular infantile (capillary) hemangioma. Curr Opin Ophthalmol. 2011;22:419–25.
Qin ZP, Li KL, Ren L, Liu XJ. Photodynamic therapy of port wine stains – a report of 238 cases. Photodiag Photodyn Ther. 2007;4:53–9.
Renfro LR, Geronemus RG, Kauvar AB. Anatomical differences of port-wine stains located on the trunk and extremities in response to treatment with the pulsed dye laser. Laser Surg Med. 1994;14(Suppl 6):47.
Reyes BA, Geronemus R. Treatment of port-wine stains during childhood with the flashlamp-pumped pulsed dye laser. J Am Acad Dermatol. 1990;23:1142–8.
Saint-Jean M, Leaute-Labreze C, Mazereeuw-Hautier J, et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64:827–32.
Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B, et al. Sturge–weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med. 2013;368:1971–9.
Stier MF, Glick SA, Hirsch RJ. Laser treatment of pediatric vascular lesions: port-wine stains and hemangiomas. J Am Acad Dermatol. 2008;58(2):261–85.
Tan OT, Sherwood K, Gilchrest BA. Treatment of children with port-wine stains using the flashlamp-pulsed tunable dye laser. N Engl J Med. 1989;320:416–21.
Vredenborg AD, Janmohamed SR, de Laat PC, et al. Multiple cutaneous infantile hemangioma and the risk of internal hemangioma. Br J Dermatol. 2013;169:188–91.
Vural E, Ramakrishnan J, Cetin N, Buckmiller L, Suen JY, Fan CY. The expression of vascular endothelial growth factor and its receptors in port-wine stains. Otolaryngol Head Neck Surg. 2008;139(4):560–4.
Waner M, Suen J. Hemangiomas and vascular malformations of the head and neck. New York: Wiley; 1999.
Woo WK, Jasim ZF, Handley JM. Evaluating the efficacy of treatment of resistant port-wine stains with variable-pulse 595-nm pulsed dye and 532-nm Nd:YAG lasers. Dermatol Surg. 2004;30:158–62.
Yang MU, Yaroslavsky AN, Farinelli WA, Flotte TJ, Rius-Diaz F, Tsao SS, et al. Long-pulsed neodymium: yttrium-aluminum-garnet laser treatment for port-wine stains. J Am Acad Dermatol. 2005;52:480–90.
Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, et al. Clinical practice guideline for the management of infantile hemangiomas. Pediatrics. 2019;143(1):e20183475.
Munden A, Butschek R, Tom WL, et al. Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies. Br J Dermatol. 2014;170:907–13.
Liu Z, Wu C, Song D, et al. Atenolol vs. propranolol for the treatment of infantile haemangiomas: a systematic review and meta-analysis. Exp Ther Med. 2020;20(2):1644–52. https://doi.org/10.3892/etm.2020.8842.
Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017;390(10089):85–94. https://doi.org/10.1016/S0140-6736(16)00645-0.
Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46. https://doi.org/10.1056/NEJMoa1404710.
Solman L, Glover M, Beattie PE, et al. Oral propranolol in the treatment of proliferating infantile haemangiomas: British Society for Paediatric Dermatology consensus guidelines. Br J Dermatol. 2018 Sep;179(3):582–9. https://doi.org/10.1111/bjd.16779.
Püttgen KB, Hansen LM, Lauren C, et al. Limited utility of repeated vital sign monitoring during initiation of oral propranolol for complicated infantile hemangioma [published online ahead of print, 2020 Apr 11]. J Am Acad Dermatol. 2020;85(2):345–52. https://doi.org/10.1016/j.jaad.2020.04.013.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Arcangeli, F., Brunelli, D. (2023). Vascular Birthmarks: Vascular Malformations and Haemangiomas. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_102
Download citation
DOI: https://doi.org/10.1007/978-3-031-15130-9_102
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15129-3
Online ISBN: 978-3-031-15130-9
eBook Packages: MedicineMedicine (R0)